Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CeraSeal vs Endoplus for Post Obturation Pain in Irreversible Pulpitis
NCT07388368Recruiting
- Sponsor
- Armed Forces Institute of Dentistry
- Start
- Jul 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Randomised, single-blind trial in irreversible pulpitis (2 arms), sponsored by Armed Forces Institute of Dentistry. Primary endpoint: Postoperative pain assessed using a Visual Analogue Scale (VAS) at 7 days. Started Jul 2026; status: recruiting.
02
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT07388368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07388368.